Literature DB >> 17637698

The vicious cycle of apoptotic beta-cell death in type 1 diabetes.

Ayelet Kaminitz1, Jerry Stein, Isaac Yaniv, Nadir Askenasy.   

Abstract

Autoimmune insulitis, the cause of type 1 diabetes, evolves through several discrete stages that culminate in beta-cell death. In the first stage, antigenic epitopes of B-cell-specific peptides are processed by antigen presenting cells in local lymph nodes, and auto-reactive lymphocyte clones are propagated. Subsequently, cell-mediated and direct cytokine-mediated reactions are generated against the beta-cells, and the beta-cells are sensitized to apoptosis. Ironically, the beta-cells themselves contribute some of the cytokines and chemokines that provoke the immune reaction within the islets. Once this vicious cycle of autoimmunity is fully developed, the fate of the beta-cells in the islets is sealed, and clinical diabetes inevitably ensues. Differences in various aspects of these concurrent events appear to underlie the significant discrepancies in experimental data observed in experimental models that simulate autoimmune insulitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637698     DOI: 10.1038/sj.icb.7100093

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  21 in total

Review 1.  Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications.

Authors:  Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2012-01-30       Impact factor: 8.401

2.  Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro.

Authors:  I Stojanovic; T Saksida; I Nikolic; F Nicoletti; S Stosic-Grujicic
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

3.  Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice.

Authors:  Anna Motterle; Sonia Gattesco; Dorothée Caille; Paolo Meda; Romano Regazzi
Journal:  Diabetologia       Date:  2015-06-03       Impact factor: 10.122

Review 4.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

5.  Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Bellur S Prabhakar; Mark J Holterman; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

6.  Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.

Authors:  Ayelet Kaminitz; Keren Mizrahi; Shifra Ash; Avi Ben-Nun; Nadir Askenasy
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

7.  Upregulation of phagocyte-like NADPH oxidase by cytokines in pancreatic beta-cells: attenuation of oxidative and nitrosative stress by 2-bromopalmitate.

Authors:  Abiy M Mohammed; Khadija Syeda; Timothy Hadden; Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2012-10-23       Impact factor: 5.858

Review 8.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

Review 9.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

10.  Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells.

Authors:  Fernanda Ortis; Najib Naamane; Daisy Flamez; Laurence Ladrière; Fabrice Moore; Daniel A Cunha; Maikel L Colli; Thomas Thykjaer; Kasper Thorsen; Torben F Orntoft; Decio L Eizirik
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.